As to IGFBP-3, higher serum IGFBP-3 levels to the increased risk of premenopausal breast cancer (Renehan et al, 2004) and distant recurrence of postmenopausal and estrogen receptor-positive breast cancer (Goodwin et al, 2002) were observed. This evidence concerns the gene ESR1 and breast cancer.